Table of Contents Table of Contents
Previous Page  58 / 464 Next Page
Information
Show Menu
Previous Page 58 / 464 Next Page
Page Background

58

PROGRAMME

| Programme and Exhibition Guide

RADIOBIOLOGY PRE-MEETING COURSE

Clinical application of biomarkers: how to discover, explore, and validate biomarkers

for normal tissue toxicity and tumour response

FRIDAY 5 MAY 2017

08:45-17:00 | LEHAR 4

Course directors: J. Alsner (DK) and MC. Vozenin (CH)

Course aim

Enable participants to understand the scientific and clinical aspects associated with

discovery, exploration, and validation of biomarkers for personalised/precision radiation

oncology (PRO) and raise awareness of key challenges in this important field.

Learning objectives

• To understand the basic principles of prognostic and predictive biomarkers

• To become familiar with biomarkers for normal tissue toxicity

• To become familiar with biomarkers for tumour response

• To appreciate the need for imaging and molecular biomarkers for PRO

• To understand the principles for validation of biomarkers

• To become familiar with legal and patent aspects for the clinical use of biomarkers.

Who should attend?

• Radiation oncologists, particularly those in the early stage of their career, who are keen

to understand how biomarkers are important for PRO

• Radiation biologists seeking information on how to maximise the clinical impact of their

scientific discoveries

• Radiation physicists and RTTs looking for an overview and update of recent and ongoing

developments in the field of biomarkers.

Programme

08:45-09:00

Introduction and overview

J. Alsner (DK)

09:00-09:30

Prognostic and predictive biomarkers

J. Alsner (DK)